US20040214240A1 - Measurement of the cell activity and cell quantity - Google Patents
Measurement of the cell activity and cell quantity Download PDFInfo
- Publication number
- US20040214240A1 US20040214240A1 US10/793,104 US79310404A US2004214240A1 US 20040214240 A1 US20040214240 A1 US 20040214240A1 US 79310404 A US79310404 A US 79310404A US 2004214240 A1 US2004214240 A1 US 2004214240A1
- Authority
- US
- United States
- Prior art keywords
- chip according
- chip
- receptor molecule
- cell
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31—Surface property or characteristic of web, sheet or block
- Y10T428/315—Surface modified glass [e.g., tempered, strengthened, etc.]
Definitions
- the present invention can directly measure cell activity, and provides a better method for early clinical diagnosis. Because it is highly sensitive, the present invention also can be used for in vitro diagnostics for cancer, autoimmune, metabolic and genetic diseases. In addition, the present invention provides an easy and inexpensive method for detecting the fixed-quantity of CD 4+cell in whole blood to help the diagnosis of AIDS and HIV infected patients. This invention not only has implications in clinical diagnosis, but also in drug development, pharmacy research, new chemical compounds research, toxicological and environmental testing. This invention has immediate commercial applications for testing cellular health as a quality control tool for cellular medicine.
- the products of cell metabolism can be measured in various ways. Acids can be detected by the change in color of a pH indicator inserted in the culture solution, and gas can be detected by the Wallbulck's gas measure.
- the quantity of the oxygen in a cell culture medium will decrease with the cell metabolism, and putting an oxygen electrode into the cell culture medium is a way to measure cell activity in real-time [I. Karube, T. Matsunaga, S. Mitsuda, S. Suzuki : Biotechnol. Bioeng., 19, 1537 (1977)].
- the impedance method detects electric change directly as cell metabolism activity [P. Cady, S. Dofour, P. Lawless, B. Nunke, and S. Kraeger, J. Clin. Microbiol., 7, 273, (1978)].
- the conductance method depends on the same principle of impedance method [J. Richard, A, Jason, G. Hobbs, D. Gibson, and R. Christie, J. Phys. E. Sci. Instrum., 11, 560, (1978)].
- the composition enzyme substrate solution method detects the quantity of the color emission or the fluorescence emission of the isolated chemical compound as enzymatic activity [M.
- the bioluminescence method detects the quantity of the ATP that is a product of cell metabolism [W. McElroy, H. Seliger, and E. H. White, Photochem. Photobiol., 10, 153, (1969)].
- the LAPS method provides a method wherein the rate of production of living cells acidic metabolites could be measured continually by a light-addressable potentiometric sensor. [J. Parce, John C. Owicki, M. Kercso, Science., 5, 243, (1989)]
- Evaluation of the activity of living cells using cytotoxicity measurements is important for assessing the effect of drugs, environmental pollutants, temperature and ionic extremes, radiation and irradiation, other cells and biological modifiers and other potentially adverse factors on cells and tissues.
- cytotoxicity measurement is a DNA assay which depends on a fluorescent dye.
- Growing living cells are dyed by 2-diamidino-phenylindole (DAPI) or Hoechst 33342, which is a fluorescent dye.
- DAPI 2-diamidino-phenylindole
- Hoechst 33342 which is a fluorescent dye.
- the fluorescence intensity of the resulting dyed cells is measured by a fluorescence photometer.
- Cells are placed in the holes of a 96-hole microtiter plate together with culture fluid and cultured for 2 days in a 37.degree. C. carbon dioxide incubator. After the culture fluid has been replaced with a new culture fluid containing a chemical substance to be tested, the chemical substance acts on the cells for 3 days.
- the culture fluid is discharged, and then the cells are fixed by a glutaraldehyde solution. Thereafter, the cells are dyed by DAPI or Hoechst 33342 solution. The fluorescence intensity of the resulting dyed cells is measured by a photometer. Finally, the cell density is determined on the assumption that control fluorescence intensity is 100%
- MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrozorlium bromide]
- MTT produces formazan due to an enzyme present in intracellular mitochondria. After formazan has been dissolved in hydrochloric acid-isopropanol, calorimetric quantization is effected. The amount of formazan is dependent on the number of live cells and therefore representative of the same.
- Cells, a culture fluid and a chemical substance solution to be tested are introduced into the holes of a 96 hole microplate and cultured for 24 hours in acid-isopropanol solution; and black crystals of formaazan are dissolved by stirring. The degrees of absorption of 570 nm light and 630 nm light are determined by a microplate reader in order to quantize the toxicity of the chemical substance.
- Sup 51 Cr take-in method is also used in cytotoxicity testing . While the 51Cr isolation method is effective with chemical substances of the kind inducing cytolytic-death in a short period of time, it is insensitive to substances of the kind that do not not fully destroy cell walls.
- The. sup.51 Cr take-in method is an improved version of the. sup.51 Cr isolation method as to its ability to decide whether cells are live or dead. Specifically, after a cell solution has been introduced in the holes of a 96-hole microplate, a chemical substance solution to be tested is added. The plate is held at 37.degree. C. for 1 hour to 8 hours, and then the top of the solution is removed by a centrifugal force. A culture fluid containing 1.
- Ci of Na.sub.2.sup.51 CrO.sub.4 is introduced into the holes of the plate-and held at 37.degree. C. for 30 minutes. After .sup.51 Cr not taken into the cells has been fully discharged, 50. l of acetic acid is added to each hole and fully stirred. All the contents of the holes are transferred to gamma counter tubes in order to measure their radioactivity.
- Flowcytometers generally are characterized as having one or more sources of excitation (typically lasers tuned to a specific frequency), means which allow the passage of cells substantially one at a time through a measurement region and means for detection of light scatter and fluorescence from cells as they pass through the measurement region. Means to record the data for each of the cells also may be coupled to the device. For example, a Trypan Blue solution is added to a cell solution, and only dead cells take it up. Trypan Blue absorbs red helium-neon laser light having a wavelength of 632.8 nm and issuing from a flowcytometer.
- sources of excitation typically lasers tuned to a specific frequency
- Means to record the data for each of the cells also may be coupled to the device. For example, a Trypan Blue solution is added to a cell solution, and only dead cells take it up. Trypan Blue absorbs red helium-neon laser light having a wavelength of 632.8 nm and issuing from a flowcytometer.
- a sample consisting of a number of cells is instantaneously divided into t groups of spots, i.e., living cells, dead cells, and cell fractions.
- the three groups of spots are drawn on an oscilloscope and allow a ratio between living cells and dead cells to be easily determined.
- Hoechst 33342 and propidium iodide are used to dye DNA of unfixed cells, activity unchanged living cells and activity injured cells fluoresce in blue and red, respectively and can therefore be easily distinguished by a flowcytometer.
- fluorescence-coated monoclonal antibody With fluorescence-coated monoclonal antibody, the quantity of cells also can be measured by flowcytometry.
- the fixed-quantity measurement of CD 4+ cell in whole blood is a test that is necessary for AIDS and HIV infected patients.
- FCM is an expensive and complex measurement. 90% of AIDS and HIV infected patients in the world can't have the fixed-quantity measurement of CD 4+ cell currently. In addition it is difficult to fix specific cells and
- This invention provides an improved method for assessing the activity and quantity of living cells which is accurate and easy and occurs in real-time.
- an antibody reacting with various proteins exposed on the surface of cells a ligand molecule reacting with various receptors exposed on the surface of cells or partial peptide thereof, or a receptor reacting with various cell adhesion factors exposed on the surface of cells or partial peptide thereof is immobilized on the inner surface of the capillary chip as a solid phase.
- a bio-specific recognition reaction a special immunity bond reaction
- washing the solid phase chip with substrate solution specific living cells can be immobilized on the inner surface of the solid phase chip.
- a sensor such as a pH electrode or an oxygen electrode or a glucose electrode. This also means it is easily possible to measure the activity and quantity of living cells specifically, accurately and quickly with the present invention.
- This invention also provides a method for immobilizing specific living cells on a solid phase chip. Further, this invention provides a method for determining the quality of a receptor-molecule solid phase chip.
- this invention provides a chip for measuring the activity or quantity of living cells.
- This invention also provides an apparatus for measuring the activity and quantity of cells.
- FIG. 1 is a schematic diagram of the present method for measuring the activity and quantity of living cells.
- FIG. 2 is a schematic diagram of the method for making the solid phase chip using charged polyion binding and chemical reaction binding
- FIG. 3 is a schematic diagram of one preferred embodiment of the apparatus of the present invention for measuring the activity and quantity of living cells
- FIG. 4 show the relative fluorescence intensity versus wavelength for the measurement of the solid phase chip binding with FITC-labelled anti-Mouse IgG via fluorescence (right picture) versus a blank control (left picture) using UV transilluminator and a charge coupled device (CCD) camera as indicator.
- FITC fluorescein isothiocyanate
- stav+ is streptavidin
- PEI is polyehtyleneimine
- BNHS biotin N hydroxysuccinimide
- FIG. 5 is an image of a microscope photograph showing CD4+ lymphocyte that has been immobilized on the inner surface of the solid phase chip using whole blood of a health volunteer as sample;
- FIG. 6 is a graph showing the change of CD4+ lymphocyte activity from a health volunteer's whole blood using super enterotoxin antigen (SEA) as a irritant agent;
- SEA super enterotoxin antigen
- FIG. 7 is an image of a microscope photograph showing neutrophils from the same volunteer's whole blood that has been immobilized on the inner surface of the solid phase chip when the health condition was good (upper picture) and the health condition was not good (lower picture), however, the quantity of neutrophils was similar when measured by hemacytometer; and
- FIG. 8 is a graph showing the change of neutrophil activity according to FIG. 7.
- the present invention provides for a receptor molecule solid phase chip for immobilizing specific living cells, an apparatus for a bio-specific recognition reaction between specific living cells and a receptor molecule solid phase chip, an apparatus for the determination of the activity and quantity of specific living cells and an apparatus for the evaluation (observation) of specific living cells morphology and quantity.
- the receptor molecule solid phase chip may be made of a polyolein polymer such as polystyrene, polyethylene, polypropylene and the like, a polyester polymer such as polyethylene terephthalate, polybutylene terephthalate and the like, a polyamide polymer such as nylon 6, nylon 6.6 and the like, and a polycarbonate, cellulose polymer such as cellulose acetate, nitrocellulose and the like.
- a polyolein polymer such as polystyrene, polyethylene, polypropylene and the like
- a polyester polymer such as polyethylene terephthalate, polybutylene terephthalate and the like
- a polyamide polymer such as nylon 6, nylon 6.6 and the like
- a polycarbonate cellulose polymer such as cellulose acetate, nitrocellulose and the like.
- the receptor molecule solid phase chip is used to measure the change of pH or oxygen be made of materials that do not absorb carbon dioxide, oxygen and other materials that may disturb the accuracy of the determination of the activity and quantity of specific living cells. It is desirable that the receptor molecule solid phase chip used is composed of glass, quartz glass, other glasses such as Li niobate, zinc selenide, porcelain, semiconductor materials such as germanium, GaAs or silicon, and metals such as aluminium, or steel.
- the solid phase chip be composed of one with a short capillary with narrow diameter.
- the inner surface of the short capillary with narrow diameter is used as the solid phase.
- bio-specific recognition reaction a special immunity bond reaction
- specific living cells can be immobilized on the inner surface of the receptor molecule solid phase chip.
- the bio-specific recognition reaction is generally based on the ability of a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells, for example of an antibody reacting with various proteins exposed on the surface of cells, a ligand molecule reacting with various receptors exposed on the surface of cells, or a receptor reacting with various cell adhesion actors exposed on the surface of cells, and to bind this molecule on the surface of cells very specifically in such a manner (see FIG. 1).
- binding methods based on ionic linkages, covalent bonds, hydrogen bonds and van der Waals forces may be used.
- the physical adsorbing method ionic binding method, chemical binding method and so on.
- biotinylated compounds adsorbing method, aminosilane coupling method and polyions charged method may be suitable and effective.
- biotinylated compounds with a large molecular weight such as biotinylated bovine serum albumin (BSA) may be used. After washing the chip with water in an ultrasound bath, the chip is treated with 0.01 and 1 mg/ml biotinylated-BSA over night. Due to van der Waals forces, biotin-BSA is strongly immobilized on the inner surface of the chip.
- BSA bovine serum albumin
- pair biotin/avidin is a very effective and strong covalent bonder
- a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells can be immobilized on the inner surface of the chip.
- a capillary that is made of glass or quartz is treated with alkali liquor or acid and washed with water in an ultrasound bath and carefully dried with nitrogen gas, which cleans the surfaces and makes them dust-free.
- aminosilane such as 3-aminopropyltriethoxysilane, 3-aminopropyldimethylethoxysilane and so on, and treating with a glutaraldehyde aqueous solution
- amino group is loaded onto the surface of the capiliary via the silane reaction.
- receptor molecule such as an antibody, or peptide directly
- the receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells can be immobilized on the inner surface of the chip with a peptide bond.
- pair biotin/avidin provides a very effective and strong covalent bond
- a sandwich binding method such as biotinylated bovine serum albumin (BSA)/streptavidin/biotinylated antibody
- BSA biotinylated bovine serum albumin
- streptavidin/biotinylated antibody a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells can be immobilized on the inner surface of the chip too.
- polyanions and polycations are required as adsorbing polyions.
- Suitable and preferred polycations are compounds with amino groups, such as polylysine, polyallylamine, polyvinylpyridine, dextrans modified with amino groups (for example DEAE-dextran), and chitosan.
- Suitable and preferred polyanions are polycarboxylic acids and polysulphonic acids. Examples of these are polyglutamate, polystyrenesulphonic acid, or dextran sulphate (see FIG. 2).
- polycations such as polyethyleneimine
- the construction of the inner surface of the solid phase chip can take place by successively alternating immersion of the support in aqueous solutions which contain polyions, for example polycations, polyanion, polycation, and so on, with rinsing processes carried out in between. Due to the opposite charge binding, the polyanion layers and poly cation layers alternate with respect to each other.
- polyions When polyions are applied, they bind horizontally and thus prevent a loss of potential binding sites in the layer below. This is additionally favoured by the fact that no discrete covalent bonds are formed, but, as a result of the electrostatic forces, a spatially fixed assignment of the ions on the various layers is not required.
- the polyions are preferably dissolved in concentrations between 1 and 100 mg/ml in the solvent, the optimum concentration depending on the molecular weight and the nature of the coating technique used and needing to be optimized in the individual case.
- a suitable solvent of the activated biotin active ester contains cyclic amides, such as dimethylformamide, dimethylacetamide, N-methylpyrrolidone and others. Since peptide bonds are formed the, biotin molecule is strongly immobilized onto the polylysine that is the toplayer of the chip.
- pair biotin/avidin provides a very effective and strong covalent bond
- a sandwich binding method such as biotin/streptavidin/biotinylated antibody
- a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells is immobilized on the inner surface of the chip.
- the process of polyion charged binding for producing the receptor molecule solid phase chip can easily be converted into a continuous procedure by passing the modified support to be coated in succession through various immersions. This reduces the amount of work considerably, compared with the other binding methods.
- the quality control of the production of the receptor molecule solid phase chip is very important in the process of producing the receptor molecule solid phase chip.
- Such testing may be done by the convenient fluorescence emission method.
- fluorescence-labelled chemical agents such as fluorescence-labelled polyanions, fluorescence-labelled polycations, fluorescence-labelled streptavidin, fluorescence-labelled biotin, fluorescence-labelled antibody and so on
- fluorescence-labelled chemical agents can be adsorbed with each different layer of the solid phase, and the quantity of the fluorescence emission can be detected with a UV transilluminator and charge coupled device (CCD) camera.
- CCD charge coupled device
- suitable conditions for producing the receptor molecule solid phase chip such as concentration of the reaction agents, reaction temperature, reaction time and so on, can be confirmed by the convenient fluorescence emission method. It is convenient, specific, effective and low cost, compared with the other testing methods.
- a normal bio-specific recognition reaction requires only immersing the receptor molecule solid phase chip in a sample including specific living cells such as cell soliquoid. However, when the sample involved contains whole blood, an apparatus for a bio-specific recognition reaction between specific living cells and a receptor molecule solid phase chip is necessary to be used to prevent corpuscle subsidence.
- the apparatus for a bio-specific recognition reaction consists of a micropump that supplies the sample including specific living cells to throw chips, and narrow diameter pipes that connect with the micropump and chips.
- a suction method may be used to supply the sample throwing chips with a perista pump, a syringe pump or a suction pump.
- a supplying rate of 1 to 100 l/min is suitable and enough for doing a bio-specific recognition reaction fully, and the pipes may be made of silicon tubes, rubber tubes and so-on.
- the apparatus for the determination of the activity and quantity of specific living cells consists of a cell having an inlet and outlet for the substrate solution, a sensor accommodated in the cell which can measure the change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells, a pump for supplying the substrate solution and antiseptic washing solution in the cell, a liquid reservoir for pooling a substrate solution, a reference electrode of the sensor in the liquid reservoir, a circuit for activating the sensor, and a means for controlling the action of the pump and reading and displaying the signal from the sensor (see FIG. 3).
- the above-mentioned sensor applies to a pH electrode, an oxygen electrode and a glucose electrode.
- a pH sensitive field-effect transistor has excellent characteristics such as: (1) it may easily be reduced in diameter; (2) it has a low amount of induced noises when reduced in diameter; (3) since it is prepared by IC techniques, the scatter of properties between electrodes can be made small and its pH sensitive plane (gate part) can be made very small; (4) it has an extremely rapid response to a pH change and has no remnant hysterisis in the response curve; (5) it has a wide linear region responsive to a pH change; and (6) it has a semipermanent life when stored in water and small change in properties such as the pH sensitivity over a period of time. Therefore, the pH-FET is most suitable for a pH electrode employed in the present invention.
- the pH-FET employed in the present invention have a pH sensitivity of 40 to 60 mV/pH, preferably 50 to 60 mV/pH at 25.degree. C.
- the leakage current is not higher than 10 nA when 1.5 V of the voltage is applied between a source electrode of the pH-FET and an outer electrode while soaking the tip part of the elemental device of the pH-FET and an outer electrode in a physiological sodium chloride solution.
- a liquid holding part is provided to the tip end of the thin tube to keep a substrate solution communicating with the pH-ISFET, then another pH-ISFET for reference and pusedo comparison electrode are fitted to the liquid holding part.
- the detection part of the sensor is provided in the cell measurement is adjacent to one end of the acceptor molecule solid phase chip or inserted into the inner of the acceptor molecule solid phase chip.
- thermostatical control such as constant temperature water bath or constant temperature atmosphere bath and like
- the temperature of the above-mentioned cell is thermostatically controlled to be 37.degree. C or other temperatures that are suitable temperatures for cell metabolism.
- the materials of the cell it may be made of cellulose polymers such as cellulose acetate, nitrocellulose and the like, or plastic, metal as well as various inorganic glasses.
- a pump for supplying the substrate solution and antiseptic washing solution in the cell supplies the substrate solution flowing through the interior of the receptor molecule solid phase chip to make the living cell metabolism continue, and the interior of the receptor molecule solid phase chip is automatically washed with the substrate solution and antiseptic washing solution.
- washing of the interior of the receptor molecule solid phase chip and measurement can be carried out in one cell and, therefore, the apparatus for determination is simplified and measurement operations are also simplified.
- a pump with a supplying rate of 1 to 1000 ml/h may be used, for example of a perista pump, a syringe pump and the like can be employed without particular limitations.
- a culture solution containing a substrate that can induce a change of pH or oxygen consumption or glucose consumption from metabolism of specific living cells may be used as a substrate solution.
- a substrate solution sugars such as glucose, fructose, sucrose and the like are most generally used.
- a culture solution having weak buffering ability is preferably used so as to sharply change the pH via metabolism by the organism.
- an enzyme that can specifically react with carbon dioxide or oxygen or glucose such as carbonic anhydrase or glucose oxidase, is added in substrate solution so as to magnify the signal of the change of pH or oxygen consumption or glucose consumption from metabolism of specific living cells.
- an antiseptic washing solution is supplied after measurement.
- Antiseptic agents such as 2-phenoxyethanol, sodium azide and the like are most generally used.
- the apparatus for the evaluation (observation) of specific living cells morphology and quantity consists of a light microscope and a microscope camera. After the above-mentioned measurement, the acceptor molecule solid phase chip is dyed by a cell stain such as Giemsa stain or Sternheimer-Malbin stain and the like. Under a light microscope, morphology and quantity of specific cells immobilized on the inner surface of acceptor molecule solid phase chip is observed carefully and a digital microscope photographs are also taken using a microscope camera in real time.
- a cell stain such as Giemsa stain or Sternheimer-Malbin stain and the like.
- all of the above-mentioned apparatuses including an apparatus for a bio-specific recognition reaction between specific living cells and a receptor molecule solid phase chip, an apparatus for the determination of activity and quantity of specific living cells and an apparatus for evaluation (observation) of specific living cells morphology may be unified to an automatic apparatus so as to further simplify all measurement operations
- bacterium, microorganism, and organelles such as mitochondria and the like may also be measured by this method.
- a substrate solution to be supplied in the cell is selected depending upon the subject to be determined.
- a normal sample solution such as a cell soliquoid is first challenged with the receptor molecule solid phase chip and allowed to stand for a constant period of time. However, when the sample contains whole blood, a sample solution is supplied throwing the receptor molecule solid phase chip with a low speed so as to prevent corpuscle subsidence.
- the receptor molecule solid phase chip is inserted into the cell.
- an operation of insertion of the receptor molecule solid phase chip in the cell may be automated by separately disposing a means for accommodating the receptor molecule solid phase chip.
- a substrate solution is supplied in the cell from a liquid reservoir by the supplying pump.
- the substrate solution supplied in the cell flows from the lower to the upper part in the receptor molecule solid phase chip and is discharged through the outlet of the cell.
- the substrate solution is sufficiently supplied and washing of the interior of the receptor molecule solid phase chip is completed, supplying solution is completed.
- the measurement cell and the receptor molecule solid phase chip are filled with a substrate solution and the the metabolism reaction of living cells is generated. Thereafter, the solution in the receptor molecule solid phase chip is moved to the sensitive part of a sensor by a pump for feeding solution, and a change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells is measured.
- the receptor molecule solid phase chip is removed from the cell and an antiseptic washing solution is supplied in the cell from the liquid reservoir by the supplying pump. Thus, the interior of the cell is automatically washed.
- a glass capillary (33 mm long, 0.65 diameter purchased from Hirschmann Laborgerate Company in Germany) was soaked in 5% nitric acid aqueous solution and treated therein at 85. degree. C. for 90 minutes. Then, it was washed with pure water in an ultrasonic bath for 10 minutes so as to clean the inner surface of dust. Finally, it was soaked in pure water, in order to be made into a receptor solid phase chip.
- the cleaned glass capillary was soaked in a polyethyleneimine solution (220 mg in10 ml H.sub.2 O) for 30 minutes at room temperature. Then, it was washed with water 10 times by wicking action and carefully dried with nitrogen gas. It was subsequently soaked in polystyrene sulfonate sodium salt solution (200 mg in10 ml 2M NaCl aqueous solution) for 20 minutes and washed with water 10 times and carefully dried with nitrogen gas. Likewise, it was subsequently soaked in poly-L-lysine solution (200 mg in10 ml 2M NaCl aqueous solution) for 20 minutes and washed with water 10 times and carefully dried with nitrogen gas.
- BNHS biotin N-hydroxysuccinimide
- the present antibody solid phase chip and a blank control chip that had only uncoated anti-human CD4 antibody were soaked in a PBS solution (pH 7.2) containing 50 g/ml FITC-labelled anti-Mouse IgG antibody (manufactured by SIGMA) for 40 minutes and washed with PBS solution (pH 7.2) 10 times. Thereafter, the present two chips were placed on a UV transilluminator (UV detection 480 nm) and the relative fluorescence intensity was detected by a charge coupled device (CCD) camera. The above-mentioned picture is shown in FIG. 4.
- This present antibody solid phase chip was connected with a perista pump by a rubber pipe (0.5 mm diameter, manufactured by NORTON) and 500 l venous blood from a healthy volunteer was sucked through challenging this chip with 15 l/min at room temperature. After all of the blood had being sucked through, this present chip was inserted into the cell of the measurement apparatus and a substrate solution was supplied in the cell using a perista pump to wash the interior of this present chip for 10 seconds.
- a substrate solution a ( ⁇ )Hanks solution containing 10 mM ammonium chloride, 1 mM potassium bicarbonate, 0.5% glucose, 0.5 mM Na.C.O.sub.3 and 0.1 mM carbonic anhydrase were prepared.
- the perista pump was stopped and 270 seconds later, 11 substrate solution in this chip was moved to the detection part of a pH sensitive field-effect transistor(pH-FET), wherein the detection part of the sensor was adjacent to the end of the present chip, and a change in the source potential was measured for 30 seconds at 37. degree.
- the present chip was subsequently removed from the cell, the perista pump was driven for 30 seconds to supply an antiseptic washing solution in the cell to wash the cell for the next measurement.
- an aqueous solution containing 0.1% sodium azide was prepared for the antiseptic washing solution.
- the present chip was soaked in Sternheimer-Malbin stain solution for 10 minutes at room temperature. Under a light microscope, the morphology and quantity of human CD4+ lymphocyte cells immobilized on the inner surface of the present chip was observed carefully and digital microscope photographs were also taken using a microscope camera in real time.
- FIG. 6 The measurement results are shown in FIG. 6. As is apparent from FIG. 6, a change of human CD4+ lymphocyte activity after cells are exposed to SEA can be measured easily and accurately using the present invention.
- FIG. 7 and FIG. 8 The measurement results are shown in FIG. 7 and FIG. 8.
- the quantity of neutrophils in whole blood is not changed at first but the activity of neutrophils is already changed.
- Fc receptors are “irritated” so as to recognize and bind much more anti-mouse IgG antibody than when the health condition of the subject person is good.
- FIG. 7 the quantity of neutrophil immobilized on the inner surface of the solid phase chip rose sharply, however, the quantity of neutrophil in whole blood was almost similar to each other.
- FIG. 8 a change of human neutrophil activity when the health condition of the subject person was changed can be measured easily and sensitively using the present invention. This means the present invention may be a novel method for early clinical diagnosis.
Abstract
This invention uses a receptor molecule such as an antibody etc immobilized to a chip for a solid phase, and a sensor such as a pH electrode or an oxygen electrode or a glucose electrode for a search device. After immobilizing specific living cells by a bio-specific recognition reaction (a special immunity bond reaction) and washing the solid phase chip, one can measure the change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells in substrate solution. This makes it possible to measure the activity and quantity of living cells specifically, accurately and quickly.
Description
- 1. Field of the Invention
- The measurement of cell activity and cell quantity is important in all fields of biotechnology and life sciences.
- In the early stages of a disease, such as inflammation, cell activity has already changed before the change in cell quantity. Instead of current diagnosis methods that measure cell quantity, the present invention can directly measure cell activity, and provides a better method for early clinical diagnosis. Because it is highly sensitive, the present invention also can be used for in vitro diagnostics for cancer, autoimmune, metabolic and genetic diseases. In addition, the present invention provides an easy and inexpensive method for detecting the fixed-quantity of CD 4+cell in whole blood to help the diagnosis of AIDS and HIV infected patients. This invention not only has implications in clinical diagnosis, but also in drug development, pharmacy research, new chemical compounds research, toxicological and environmental testing. This invention has immediate commercial applications for testing cellular health as a quality control tool for cellular medicine.
- 2. The Prior Art
- In order to measure cell activity, the products of cell metabolism can be measured in various ways. Acids can be detected by the change in color of a pH indicator inserted in the culture solution, and gas can be detected by the Wallbulck's gas measure. The quantity of the oxygen in a cell culture medium will decrease with the cell metabolism, and putting an oxygen electrode into the cell culture medium is a way to measure cell activity in real-time [I. Karube, T. Matsunaga, S. Mitsuda, S. Suzuki : Biotechnol. Bioeng., 19, 1537 (1977)].
- Additionally, methods such as enzyme assays, electrochemistry assays, and chemistry fluorescence emission assays are used for testing cell activity. For example, the impedance method detects electric change directly as cell metabolism activity [P. Cady, S. Dofour, P. Lawless, B. Nunke, and S. Kraeger, J. Clin. Microbiol., 7, 273, (1978)]. The conductance method depends on the same principle of impedance method [J. Richard, A, Jason, G. Hobbs, D. Gibson, and R. Christie, J. Phys. E. Sci. Instrum., 11, 560, (1978)].The composition enzyme substrate solution method detects the quantity of the color emission or the fluorescence emission of the isolated chemical compound as enzymatic activity [M. Manafi, and W. Kneifel, Acta Microbial. Hungarica 38, 293, (1991)]. The bioluminescence method detects the quantity of the ATP that is a product of cell metabolism [W. McElroy, H. Seliger, and E. H. White, Photochem. Photobiol., 10, 153, (1969)].The LAPS method provides a method wherein the rate of production of living cells acidic metabolites could be measured continually by a light-addressable potentiometric sensor. [J. Parce, John C. Owicki, M. Kercso, Science., 5, 243, (1989)]
- Evaluation of the activity of living cells using cytotoxicity measurements is important for assessing the effect of drugs, environmental pollutants, temperature and ionic extremes, radiation and irradiation, other cells and biological modifiers and other potentially adverse factors on cells and tissues.
- One such cytotoxicity measurement is a DNA assay which depends on a fluorescent dye. Growing living cells are dyed by 2-diamidino-phenylindole (DAPI) or Hoechst 33342, which is a fluorescent dye. The fluorescence intensity of the resulting dyed cells is measured by a fluorescence photometer. Cells are placed in the holes of a 96-hole microtiter plate together with culture fluid and cultured for 2 days in a 37.degree. C. carbon dioxide incubator. After the culture fluid has been replaced with a new culture fluid containing a chemical substance to be tested, the chemical substance acts on the cells for 3 days. Subsequently, the culture fluid is discharged, and then the cells are fixed by a glutaraldehyde solution. Thereafter, the cells are dyed by DAPI or Hoechst 33342 solution. The fluorescence intensity of the resulting dyed cells is measured by a photometer. Finally, the cell density is determined on the assumption that control fluorescence intensity is 100%
- Another cytotoxicity testing method uses MTT ([3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrozorlium bromide]). MTT produces formazan due to an enzyme present in intracellular mitochondria. After formazan has been dissolved in hydrochloric acid-isopropanol, calorimetric quantization is effected. The amount of formazan is dependent on the number of live cells and therefore representative of the same. Cells, a culture fluid and a chemical substance solution to be tested are introduced into the holes of a 96 hole microplate and cultured for 24 hours in acid-isopropanol solution; and black crystals of formaazan are dissolved by stirring. The degrees of absorption of 570 nm light and 630 nm light are determined by a microplate reader in order to quantize the toxicity of the chemical substance.
- Sup 51 Cr take-in method is also used in cytotoxicity testing . While the 51Cr isolation method is effective with chemical substances of the kind inducing cytolytic-death in a short period of time, it is insensitive to substances of the kind that do not not fully destroy cell walls. The. sup.51 Cr take-in method is an improved version of the. sup.51 Cr isolation method as to its ability to decide whether cells are live or dead. Specifically, after a cell solution has been introduced in the holes of a 96-hole microplate, a chemical substance solution to be tested is added. The plate is held at 37.degree. C. for 1 hour to 8 hours, and then the top of the solution is removed by a centrifugal force. A culture fluid containing 1. Ci of Na.sub.2.sup.51 CrO.sub.4 is introduced into the holes of the plate-and held at 37.degree. C. for 30 minutes. After .sup.51 Cr not taken into the cells has been fully discharged, 50. l of acetic acid is added to each hole and fully stirred. All the contents of the holes are transferred to gamma counter tubes in order to measure their radioactivity.
- In all of these above-mentioned methods, it takes a long time to culture living cells. Usually, cultured cells form irregular colonies in which cells high in activity and growth ability and cells low in-the same exist together. Only cell concentrations above 106cells/M1 can be detected using these methods. In addition, all of these methods require skill and complicated operations as well as expensive apparatus for determination. Furthermore, as they are sometimes inaccurate and insensitive, these methods are not suitable for clinical diagnosis.
- The most useful method for detecting the activity and the quantity of living cells is flow cytometry. Flowcytometers generally are characterized as having one or more sources of excitation (typically lasers tuned to a specific frequency), means which allow the passage of cells substantially one at a time through a measurement region and means for detection of light scatter and fluorescence from cells as they pass through the measurement region. Means to record the data for each of the cells also may be coupled to the device. For example, a Trypan Blue solution is added to a cell solution, and only dead cells take it up. Trypan Blue absorbs red helium-neon laser light having a wavelength of 632.8 nm and issuing from a flowcytometer. Therefore, a sample consisting of a number of cells is instantaneously divided into t groups of spots, i.e., living cells, dead cells, and cell fractions. The three groups of spots are drawn on an oscilloscope and allow a ratio between living cells and dead cells to be easily determined. When Hoechst 33342 and propidium iodide are used to dye DNA of unfixed cells, activity unchanged living cells and activity injured cells fluoresce in blue and red, respectively and can therefore be easily distinguished by a flowcytometer. With fluorescence-coated monoclonal antibody, the quantity of cells also can be measured by flowcytometry. The fixed-quantity measurement of CD 4+ cell in whole blood is a test that is necessary for AIDS and HIV infected patients. However FCM is an expensive and complex measurement. 90% of AIDS and HIV infected patients in the world can't have the fixed-quantity measurement of CD 4+ cell currently. In addition it is difficult to fix specific cells and a sufficient amount of sample is necessary for this test.
- This invention provides an improved method for assessing the activity and quantity of living cells which is accurate and easy and occurs in real-time. Using charged polyion binding or chemical reaction bonding or covalent bonding, an antibody reacting with various proteins exposed on the surface of cells, a ligand molecule reacting with various receptors exposed on the surface of cells or partial peptide thereof, or a receptor reacting with various cell adhesion factors exposed on the surface of cells or partial peptide thereof is immobilized on the inner surface of the capillary chip as a solid phase. After a bio-specific recognition reaction (a special immunity bond reaction) and washing the solid phase chip with substrate solution, specific living cells can be immobilized on the inner surface of the solid phase chip. As living cells are dipped in the substrate solution including some culture ingredients like glucose, it is possible to measure the change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells by a sensor such as a pH electrode or an oxygen electrode or a glucose electrode. This also means it is easily possible to measure the activity and quantity of living cells specifically, accurately and quickly with the present invention.
- This invention also provides a method for immobilizing specific living cells on a solid phase chip. Further, this invention provides a method for determining the quality of a receptor-molecule solid phase chip.
- Additionally, this invention provides a chip for measuring the activity or quantity of living cells.
- This invention also provides an apparatus for measuring the activity and quantity of cells.
- FIG. 1 is a schematic diagram of the present method for measuring the activity and quantity of living cells.;
- FIG. 2 is a schematic diagram of the method for making the solid phase chip using charged polyion binding and chemical reaction binding;
- FIG. 3 is a schematic diagram of one preferred embodiment of the apparatus of the present invention for measuring the activity and quantity of living cells;
- FIG. 4 show the relative fluorescence intensity versus wavelength for the measurement of the solid phase chip binding with FITC-labelled anti-Mouse IgG via fluorescence (right picture) versus a blank control (left picture) using UV transilluminator and a charge coupled device (CCD) camera as indicator.; (FITC is fluorescein isothiocyanate, stav+ is streptavidin, PEI is polyehtyleneimine, and BNHS is biotin N hydroxysuccinimide)
- FIG. 5 is an image of a microscope photograph showing CD4+ lymphocyte that has been immobilized on the inner surface of the solid phase chip using whole blood of a health volunteer as sample;
- FIG. 6 is a graph showing the change of CD4+ lymphocyte activity from a health volunteer's whole blood using super enterotoxin antigen (SEA) as a irritant agent;
- FIG. 7 is an image of a microscope photograph showing neutrophils from the same volunteer's whole blood that has been immobilized on the inner surface of the solid phase chip when the health condition was good (upper picture) and the health condition was not good (lower picture), however, the quantity of neutrophils was similar when measured by hemacytometer; and
- FIG. 8 is a graph showing the change of neutrophil activity according to FIG. 7.
- Referring to FIGS. 1-8 of the drawings, the present invention provides for a receptor molecule solid phase chip for immobilizing specific living cells, an apparatus for a bio-specific recognition reaction between specific living cells and a receptor molecule solid phase chip, an apparatus for the determination of the activity and quantity of specific living cells and an apparatus for the evaluation (observation) of specific living cells morphology and quantity.
- The receptor molecule solid phase chip may be made of a polyolein polymer such as polystyrene, polyethylene, polypropylene and the like, a polyester polymer such as polyethylene terephthalate, polybutylene terephthalate and the like, a polyamide polymer such as nylon 6, nylon 6.6 and the like, and a polycarbonate, cellulose polymer such as cellulose acetate, nitrocellulose and the like.
- Since the receptor molecule solid phase chip is used to measure the change of pH or oxygen be made of materials that do not absorb carbon dioxide, oxygen and other materials that may disturb the accuracy of the determination of the activity and quantity of specific living cells. It is desirable that the receptor molecule solid phase chip used is composed of glass, quartz glass, other glasses such as Li niobate, zinc selenide, porcelain, semiconductor materials such as germanium, GaAs or silicon, and metals such as aluminium, or steel.
- In order to provide the chip wherein a small quantity of the sample may be used, and one that is inexpensive and easy to use to carry out the measurement, it is desirable that the solid phase chip be composed of one with a short capillary with narrow diameter. The inner surface of the short capillary with narrow diameter is used as the solid phase.
- After a bio-specific recognition reaction (a special immunity bond reaction), specific living cells can be immobilized on the inner surface of the receptor molecule solid phase chip. The bio-specific recognition reaction (special immunity bond reaction) is generally based on the ability of a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells, for example of an antibody reacting with various proteins exposed on the surface of cells, a ligand molecule reacting with various receptors exposed on the surface of cells, or a receptor reacting with various cell adhesion actors exposed on the surface of cells, and to bind this molecule on the surface of cells very specifically in such a manner (see FIG. 1).
- To immobilize a receptor molecule on the inner surface of the chip, several binding methods based on ionic linkages, covalent bonds, hydrogen bonds and van der Waals forces may be used. For example the physical adsorbing method, ionic binding method, chemical binding method and so on. Furthermore, in the present invention, biotinylated compounds adsorbing method, aminosilane coupling method and polyions charged method may be suitable and effective.
- According to the biotinylated compound adsorbing method, biotinylated compounds with a large molecular weight such as biotinylated bovine serum albumin (BSA) may be used. After washing the chip with water in an ultrasound bath, the chip is treated with 0.01 and 1 mg/ml biotinylated-BSA over night. Due to van der Waals forces, biotin-BSA is strongly immobilized on the inner surface of the chip. Then, as pair biotin/avidin is a very effective and strong covalent bonder, using a sandwich binding method with streptavidin and biotinylated antibody and the like, a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells can be immobilized on the inner surface of the chip.
- According to the aminosilane coupling method, a capillary that is made of glass or quartz is treated with alkali liquor or acid and washed with water in an ultrasound bath and carefully dried with nitrogen gas, which cleans the surfaces and makes them dust-free.
- After reacting with the aminosilane such as 3-aminopropyltriethoxysilane, 3-aminopropyldimethylethoxysilane and so on, and treating with a glutaraldehyde aqueous solution, amino group is loaded onto the surface of the capiliary via the silane reaction. Finally reacting with the receptor molecule such as an antibody, or peptide directly, the receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells can be immobilized on the inner surface of the chip with a peptide bond.
- Furthermore, as pair biotin/avidin provides a very effective and strong covalent bond, using a sandwich binding method, such as biotinylated bovine serum albumin (BSA)/streptavidin/biotinylated antibody, a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells can be immobilized on the inner surface of the chip too.
- According to the polyion charged method, which is the preferred embodiment of the invention, polyanions and polycations are required as adsorbing polyions. Suitable and preferred polycations are compounds with amino groups, such as polylysine, polyallylamine, polyvinylpyridine, dextrans modified with amino groups (for example DEAE-dextran), and chitosan. Suitable and preferred polyanions are polycarboxylic acids and polysulphonic acids. Examples of these are polyglutamate, polystyrenesulphonic acid, or dextran sulphate (see FIG. 2).
- Furthermore, on glass or quartz, it is possible to adsorb polycations, such as polyethyleneimine, after briefly dipping it into water or sodium hydroxide solution. The construction of the inner surface of the solid phase chip can take place by successively alternating immersion of the support in aqueous solutions which contain polyions, for example polycations, polyanion, polycation, and so on, with rinsing processes carried out in between. Due to the opposite charge binding, the polyanion layers and poly cation layers alternate with respect to each other.
- When polyions are applied, they bind horizontally and thus prevent a loss of potential binding sites in the layer below. This is additionally favoured by the fact that no discrete covalent bonds are formed, but, as a result of the electrostatic forces, a spatially fixed assignment of the ions on the various layers is not required.
- The polyions are preferably dissolved in concentrations between 1 and 100 mg/ml in the solvent, the optimum concentration depending on the molecular weight and the nature of the coating technique used and needing to be optimized in the individual case.
- After the toplayer is coated using polylysine as a polycation, the chip reacts with the activated biotin active ester (biotin N-hydroxysuccinimide=BNHS) using triethylamine as a pH adjuster for at least more than 4 hours. A suitable solvent of the activated biotin active ester contains cyclic amides, such as dimethylformamide, dimethylacetamide, N-methylpyrrolidone and others. Since peptide bonds are formed the, biotin molecule is strongly immobilized onto the polylysine that is the toplayer of the chip.
- Finally, as pair biotin/avidin provides a very effective and strong covalent bond, using a sandwich binding method, such as biotin/streptavidin/biotinylated antibody, a receptor molecule recognizing specifically the structure and molecular organization of a ligand molecule on the surface of specific living cells is immobilized on the inner surface of the chip.
- The process of polyion charged binding for producing the receptor molecule solid phase chip can easily be converted into a continuous procedure by passing the modified support to be coated in succession through various immersions. This reduces the amount of work considerably, compared with the other binding methods.
- The quality control of the production of the receptor molecule solid phase chip, for-example testing whether the receptor molecule is immobilized on the inner surface of chip or whether the homogeneity of the each different layer of the solid phase is good, is very important in the process of producing the receptor molecule solid phase chip.
- Such testing may be done by the convenient fluorescence emission method. After reacting with varieties of fluorescence-labelled chemical agents such as fluorescence-labelled polyanions, fluorescence-labelled polycations, fluorescence-labelled streptavidin, fluorescence-labelled biotin, fluorescence-labelled antibody and so on, fluorescence-labelled chemical agents can be adsorbed with each different layer of the solid phase, and the quantity of the fluorescence emission can be detected with a UV transilluminator and charge coupled device (CCD) camera.
- Furthermore, suitable conditions for producing the receptor molecule solid phase chip such as concentration of the reaction agents, reaction temperature, reaction time and so on, can be confirmed by the convenient fluorescence emission method. It is convenient, specific, effective and low cost, compared with the other testing methods.
- A normal bio-specific recognition reaction requires only immersing the receptor molecule solid phase chip in a sample including specific living cells such as cell soliquoid. However, when the sample involved contains whole blood, an apparatus for a bio-specific recognition reaction between specific living cells and a receptor molecule solid phase chip is necessary to be used to prevent corpuscle subsidence.
- The apparatus for a bio-specific recognition reaction consists of a micropump that supplies the sample including specific living cells to throw chips, and narrow diameter pipes that connect with the micropump and chips.
- A suction method may be used to supply the sample throwing chips with a perista pump, a syringe pump or a suction pump. In addition, a supplying rate of 1 to 100 l/min is suitable and enough for doing a bio-specific recognition reaction fully, and the pipes may be made of silicon tubes, rubber tubes and so-on.
- The apparatus for the determination of the activity and quantity of specific living cells consists of a cell having an inlet and outlet for the substrate solution, a sensor accommodated in the cell which can measure the change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells, a pump for supplying the substrate solution and antiseptic washing solution in the cell, a liquid reservoir for pooling a substrate solution, a reference electrode of the sensor in the liquid reservoir, a circuit for activating the sensor, and a means for controlling the action of the pump and reading and displaying the signal from the sensor (see FIG. 3).
- To measure the change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells, the above-mentioned sensor applies to a pH electrode, an oxygen electrode and a glucose electrode.
- According to the pH electrode, a pH sensitive field-effect transistor (pH-FET) has excellent characteristics such as: (1) it may easily be reduced in diameter; (2) it has a low amount of induced noises when reduced in diameter; (3) since it is prepared by IC techniques, the scatter of properties between electrodes can be made small and its pH sensitive plane (gate part) can be made very small; (4) it has an extremely rapid response to a pH change and has no remnant hysterisis in the response curve; (5) it has a wide linear region responsive to a pH change; and (6) it has a semipermanent life when stored in water and small change in properties such as the pH sensitivity over a period of time. Therefore, the pH-FET is most suitable for a pH electrode employed in the present invention.
- It is desirable that the pH-FET employed in the present invention have a pH sensitivity of 40 to 60 mV/pH, preferably 50 to 60 mV/pH at 25.degree. C.
- In addition, it is desirable that the leakage current is not higher than 10 nA when 1.5 V of the voltage is applied between a source electrode of the pH-FET and an outer electrode while soaking the tip part of the elemental device of the pH-FET and an outer electrode in a physiological sodium chloride solution.
- In order to improve the measuring accuracy by suppressing the influence of drift due to various factors, a liquid holding part is provided to the tip end of the thin tube to keep a substrate solution communicating with the pH-ISFET, then another pH-ISFET for reference and pusedo comparison electrode are fitted to the liquid holding part.
- According to the position of the sensor, the detection part of the sensor is provided in the cell measurement is adjacent to one end of the acceptor molecule solid phase chip or inserted into the inner of the acceptor molecule solid phase chip.
- On the other hand, with thermostatical control such as constant temperature water bath or constant temperature atmosphere bath and like, the temperature of the above-mentioned cell is thermostatically controlled to be 37.degree. C or other temperatures that are suitable temperatures for cell metabolism. According to the materials of the cell, it may be made of cellulose polymers such as cellulose acetate, nitrocellulose and the like, or plastic, metal as well as various inorganic glasses.
- A pump for supplying the substrate solution and antiseptic washing solution in the cell supplies the substrate solution flowing through the interior of the receptor molecule solid phase chip to make the living cell metabolism continue, and the interior of the receptor molecule solid phase chip is automatically washed with the substrate solution and antiseptic washing solution. Thus, washing of the interior of the receptor molecule solid phase chip and measurement can be carried out in one cell and, therefore, the apparatus for determination is simplified and measurement operations are also simplified.
- A pump with a supplying rate of 1 to 1000 ml/h may be used, for example of a perista pump, a syringe pump and the like can be employed without particular limitations.
- For determining the change of pH or oxygen consumption or glucose consumption from metabolism of specific living cells, a culture solution containing a substrate that can induce a change of pH or oxygen consumption or glucose consumption from metabolism of specific living cells may be used as a substrate solution. As the substrate, sugars such as glucose, fructose, sucrose and the like are most generally used. In this ease, a culture solution having weak buffering ability is preferably used so as to sharply change the pH via metabolism by the organism. In addition, an enzyme that can specifically react with carbon dioxide or oxygen or glucose, such as carbonic anhydrase or glucose oxidase, is added in substrate solution so as to magnify the signal of the change of pH or oxygen consumption or glucose consumption from metabolism of specific living cells.
- In order to prevent pollution of the sensor and cell by samples such as whole blood and culture substrate, an antiseptic washing solution is supplied after measurement. Antiseptic agents such as 2-phenoxyethanol, sodium azide and the like are most generally used.
- The apparatus for the evaluation (observation) of specific living cells morphology and quantity consists of a light microscope and a microscope camera. After the above-mentioned measurement, the acceptor molecule solid phase chip is dyed by a cell stain such as Giemsa stain or Sternheimer-Malbin stain and the like. Under a light microscope, morphology and quantity of specific cells immobilized on the inner surface of acceptor molecule solid phase chip is observed carefully and a digital microscope photographs are also taken using a microscope camera in real time.
- In addition, after dyeing the solid phase chip, color areas and quantity of color (stain) emission of all specific cells and one specific cell may be measured by a charge coupled device. Therefore, quantity of the specific cells can be calculated easily.
- Further, all of the above-mentioned apparatuses including an apparatus for a bio-specific recognition reaction between specific living cells and a receptor molecule solid phase chip, an apparatus for the determination of activity and quantity of specific living cells and an apparatus for evaluation (observation) of specific living cells morphology may be unified to an automatic apparatus so as to further simplify all measurement operations
- In addition to specific living eukaryotic cells, bacterium, microorganism, and organelles such as mitochondria and the like may also be measured by this method. In this case, a substrate solution to be supplied in the cell is selected depending upon the subject to be determined.
- A method for determination employing the present apparatus is described as follows:
- A normal sample solution such as a cell soliquoid is first challenged with the receptor molecule solid phase chip and allowed to stand for a constant period of time. However, when the sample contains whole blood, a sample solution is supplied throwing the receptor molecule solid phase chip with a low speed so as to prevent corpuscle subsidence.
- Then, after the bio-specific recognition reaction is completed, the receptor molecule solid phase chip is inserted into the cell. Alternatively, an operation of insertion of the receptor molecule solid phase chip in the cell may be automated by separately disposing a means for accommodating the receptor molecule solid phase chip.
- With the receptor molecule solid phase chip accommodated in the cell as described above, a substrate solution is supplied in the cell from a liquid reservoir by the supplying pump. The substrate solution supplied in the cell flows from the lower to the upper part in the receptor molecule solid phase chip and is discharged through the outlet of the cell.
- When the substrate solution is sufficiently supplied and washing of the interior of the receptor molecule solid phase chip is completed, supplying solution is completed. The measurement cell and the receptor molecule solid phase chip are filled with a substrate solution and the the metabolism reaction of living cells is generated. Thereafter, the solution in the receptor molecule solid phase chip is moved to the sensitive part of a sensor by a pump for feeding solution, and a change of pH or oxygen consumption or glucose consumption from the metabolism of the specific living cells is measured.
- Analyzing these changes from the metabolism of the specific living cells with a special soft (least square method, peak area method and etc), the activity and quantity of living cells to be determined accurately and quickly.
- After measurement is completed, the receptor molecule solid phase chip is removed from the cell and an antiseptic washing solution is supplied in the cell from the liquid reservoir by the supplying pump. Thus, the interior of the cell is automatically washed.
- Finally, after dyeing the receptor molecule solid phase chip, the morphology and quantity of specific cells immobilized on the inner surface of acceptor molecule solid phase chip is observed carefully with a light microscope and a microscope camera or another apparatus.
- The following experiments are provided for purposes of illustration and not for limitation
- Experiment 1
- Measurement of human CD4+ lymphocyte activity
- 1. Manufacture of a receptor solid phase chip
- A glass capillary (33 mm long, 0.65 diameter purchased from Hirschmann Laborgerate Company in Germany) was soaked in 5% nitric acid aqueous solution and treated therein at 85. degree. C. for 90 minutes. Then, it was washed with pure water in an ultrasonic bath for 10 minutes so as to clean the inner surface of dust. Finally, it was soaked in pure water, in order to be made into a receptor solid phase chip.
- The cleaned glass capillary was soaked in a polyethyleneimine solution (220 mg in10 ml H.sub.2 O) for 30 minutes at room temperature. Then, it was washed with
water 10 times by wicking action and carefully dried with nitrogen gas. It was subsequently soaked in polystyrene sulfonate sodium salt solution (200 mg in10 ml 2M NaCl aqueous solution) for 20 minutes and washed withwater 10 times and carefully dried with nitrogen gas. Likewise, it was subsequently soaked in poly-L-lysine solution (200 mg in10 ml 2M NaCl aqueous solution) for 20 minutes and washed withwater 10 times and carefully dried with nitrogen gas. It was subsequently soaked in biotin N-hydroxysuccinimide (BNHS) solution (200 mg in 10 ml dimethylformamide add 50 l triethylamine as a pH adjuster) over night at room temperature. After being washed withwater 10 times and carefully dried with nitrogen gas, the capillary was soaked in a PBS solution (pH 7.2) containing 100 g/ml of streptavidin for 30 minutes and washed with PBS solution (pH 7.2) 10 times. Finally, it was soaked in a PBS solution (pH 7.2) containing 50 g/ml biotinylated anti-human CD4 antibody (manufactured by IMMUNOTECH, clone 13B8.2) for 40 minutes and washed with PBS solution (pH 7.2) 10 times. - For testing whether the anti-human CD4 antibody was immobilized on the inner surface of the present chip, the present antibody solid phase chip and a blank control chip that had only uncoated anti-human CD4 antibody were soaked in a PBS solution (pH 7.2) containing 50 g/ml FITC-labelled anti-Mouse IgG antibody (manufactured by SIGMA) for 40 minutes and washed with PBS solution (pH 7.2) 10 times. Thereafter, the present two chips were placed on a UV transilluminator (UV detection 480 nm) and the relative fluorescence intensity was detected by a charge coupled device (CCD) camera. The above-mentioned picture is shown in FIG. 4.
- 2. Measurement of human CD4+ lymphocyte activity
- This present antibody solid phase chip was connected with a perista pump by a rubber pipe (0.5 mm diameter, manufactured by NORTON) and 500 l venous blood from a healthy volunteer was sucked through challenging this chip with 15 l/min at room temperature. After all of the blood had being sucked through, this present chip was inserted into the cell of the measurement apparatus and a substrate solution was supplied in the cell using a perista pump to wash the interior of this present chip for 10 seconds. As a substrate solution, a (−)Hanks solution containing 10 mM ammonium chloride, 1 mM potassium bicarbonate, 0.5% glucose, 0.5 mM Na.C.O.sub.3 and 0.1 mM carbonic anhydrase were prepared. Thereafter, the perista pump was stopped and 270 seconds later, 11 substrate solution in this chip was moved to the detection part of a pH sensitive field-effect transistor(pH-FET), wherein the detection part of the sensor was adjacent to the end of the present chip, and a change in the source potential was measured for 30 seconds at 37. degree. The present chip was subsequently removed from the cell, the perista pump was driven for 30 seconds to supply an antiseptic washing solution in the cell to wash the cell for the next measurement. For the antiseptic washing solution, an aqueous solution containing 0.1% sodium azide was prepared.
- After the measurement was completed, the present chip was soaked in Sternheimer-Malbin stain solution for 10 minutes at room temperature. Under a light microscope, the morphology and quantity of human CD4+ lymphocyte cells immobilized on the inner surface of the present chip was observed carefully and digital microscope photographs were also taken using a microscope camera in real time.
- 3. Results
- The same blood sample was continually measured two times by the present antibody solid phase chip under the same conditions. The results are described in the following table.
Blank chip The 1st time Of the The 2st time of the (n = 3) antibody chip (n = 3) antibody chip (n = 3) Mean 0.02 mV 23.71 mV 22.98 mV activity SD ±0.013 ±0.035 ±0.028 CV % 0.126% 0.204% 0.169% - As is apparent from the above table, the activity of human CD4+ lymphocyte cells can be selectively, quickly and continually measured with an excellent repeat using the present invention. Furthermore, as is shown in FIG. 5, morphology and quantity of human CD4+ lymphocyte cells can be clearly observed.
- Experiment 2
- The measurement of a change of human CD4+ lymphocyte activity after cells are subjected to SEA
- 1. Manufacture of a receptor solid phase chip was as same as experiment 1.
- 2. Measurement of a change of human CD4+ lymphocyte activity after cells were subjected to the SEA
- The process of the measurement was almost as same as experiment 1, however, in addition to the substrate solution used in experiment 1, a substrate solution containing 10 g/ml super enterotoxins antigen (SEA) was used
- 3. Results
- The measurement results are shown in FIG. 6. As is apparent from FIG. 6, a change of human CD4+ lymphocyte activity after cells are exposed to SEA can be measured easily and accurately using the present invention.
- Experiment 3
- The measurement of a change of human neutrophil activity when health condition of the subject person was different
- 1. Manufacture of a receptor solid phase chip
- Except for the receptor being changed to 50 g/ml biotinylated anti-mouse IgG antibody (manufactured by SIGMA), the process was as same experiment 1. There are Fc receptors on the surface of neutrophil, so anti-mouse IgG antibody that has Fc parts was used as a receptor to be immobilized on the surface of chip.
- 2. Measurement of a change of human neutrophil activity when health condition of the subject person was different
- As a sample, venous blood drawn from the same person on different days was prepared. However, the health condition of the subject person on different days was different. Furthermore, the quantity of neutrophils in whole blood was measured by hemacytometer before the measurement. The other processes were the same as experiment 1.
- 3. Results
- The measurement results are shown in FIG. 7 and FIG. 8. When the health condition of the subject person is not good, the quantity of neutrophils in whole blood is not changed at first but the activity of neutrophils is already changed. Especially, Fc receptors are “irritated” so as to recognize and bind much more anti-mouse IgG antibody than when the health condition of the subject person is good. As is shown in FIG. 7, the quantity of neutrophil immobilized on the inner surface of the solid phase chip rose sharply, however, the quantity of neutrophil in whole blood was almost similar to each other. In addition, as is apparent from FIG. 8, a change of human neutrophil activity when the health condition of the subject person was changed can be measured easily and sensitively using the present invention. This means the present invention may be a novel method for early clinical diagnosis.
- While presently preferred embodiments have been described for the purposes of the disclosure, numerous changes in the arrangement, methods, steps and apparatus parts can be made by those skilled in the art. Such changes are encompassed within the spirit of the invention by the appended claims.
Claims (21)
1-43 (cancelled)
44: A chip for immobilizing at least one specific living cell or at least one specific living organelle in a sample, comprising:
(a) a surface comprising polyionic layers in an alternating arrangement of at least one polyanion layer and at least one polycation layer substantially parallel to the surface of said chip; and
(b) at least one receptor molecule affixed to said surface and capable of binding a specific molecule on a surface of said at least one specific living cell or organelle.
45: The chip according to claim 44 , wherein said polyionic layers comprise at least one amphiphilic layer.
46: The chip according to claim 44 , wherein said surface comprises a material selected from the group consisting of a polymer, a glass, a semiconductor material, a metal, and a combination thereof.
47: The chip according to claim 44 , wherein said surface comprises a capillary.
48 The chip according to claim 47 , wherein said at least one receptor molecule is affixed to the inner surface of the capillary.
49: The chip according to claim 44 , wherein said at least one receptor molecule is selected from the group consisting of at least one antibody, at least one ligand molecule, and at least one receptor.
50: The chip according to claim 44 , wherein said at least one receptor molecule is affixed to the top polyionic layer of said surface by a binding method comprising covalent binding.
51: The chip according to claim 44 , wherein said at least one receptor molecule is affixed to the top polyionic layer of said surface by a binding method comprising non-covalent binding.
52: The chip according to claim 44 , wherein said at least one receptor molecule is affixed to the top polyionic layer of said surface by a binding method comprising a combination of covalent and non-covalent binding.
53: The chip according to claim 44 , wherein said at least one receptor molecule is affixed to the top polyionic layer of said surface by a binding method comprising biotin-avidin binding.
54: The chip according to claim 44 , wherein said at least one receptor molecule is affixed to the top polyionic layer of said surface by a binding method comprising aminosilane coupling.
55: The chip according to claim 44 , wherein said sample comprises whole blood.
56: The chip according to claim 44 , wherein said at least one specific living cell comprises a T-lymphocyte.
57: The chip according to claim 56 , wherein said T-lymphocyte comprises a CD4+ T-lymphocyte.
58: The chip according to claim 44 , wherein said specific molecule on the surface of said at least one specific living cell or organelle comprises a CD antigen.
59: The chip according to claim 58 , wherein said CD antigen comprises a CD4 antigen.
60: An apparatus for measuring at least one measurement of at least one specific living cell or at least one specific living organelle in a sample, comprising:
(a) the chip according to claim 44;
(b) at least one pumping means; and
(c) at least one detection device.
61: The apparatus according to claim 60 , wherein said at least one measurement of said at least one specific living cell or organelle is selected from the group consisting of quantity, morphology, physiological activity, and a combination thereof.
62: The apparatus according to claim 60 , wherein said pumping means is capable of pumping at least one of the group consisting of a sample solution, a wash solution, a reagent solution, a substrate solution, a labelling solution, and a combination thereof.
63: The apparatus according to claim 60 , wherein said at least one detection device is comprises at least one detector selected from the group consisting of a pH sensor, a gas sensor, a metabolite sensor, a microscope, a camera, a charge-coupled device, and a combination thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/793,104 US20040214240A1 (en) | 2002-04-25 | 2004-03-03 | Measurement of the cell activity and cell quantity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/132,543 US7141369B2 (en) | 2002-04-25 | 2002-04-25 | Measuring cellular metabolism of immobilized cells |
US10/793,104 US20040214240A1 (en) | 2002-04-25 | 2004-03-03 | Measurement of the cell activity and cell quantity |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/132,543 Division US7141369B2 (en) | 2002-04-25 | 2002-04-25 | Measuring cellular metabolism of immobilized cells |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040214240A1 true US20040214240A1 (en) | 2004-10-28 |
Family
ID=29248796
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/132,543 Expired - Lifetime US7141369B2 (en) | 2002-04-25 | 2002-04-25 | Measuring cellular metabolism of immobilized cells |
US10/420,643 Active 2027-07-02 US7855068B2 (en) | 2002-04-25 | 2003-04-22 | Methods and kits for detecting a target cell |
US10/793,104 Abandoned US20040214240A1 (en) | 2002-04-25 | 2004-03-03 | Measurement of the cell activity and cell quantity |
US11/655,607 Abandoned US20070134713A1 (en) | 2002-04-25 | 2007-01-18 | Methods and kits for detecting a target cell |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/132,543 Expired - Lifetime US7141369B2 (en) | 2002-04-25 | 2002-04-25 | Measuring cellular metabolism of immobilized cells |
US10/420,643 Active 2027-07-02 US7855068B2 (en) | 2002-04-25 | 2003-04-22 | Methods and kits for detecting a target cell |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/655,607 Abandoned US20070134713A1 (en) | 2002-04-25 | 2007-01-18 | Methods and kits for detecting a target cell |
Country Status (3)
Country | Link |
---|---|
US (4) | US7141369B2 (en) |
AU (1) | AU2003223695A1 (en) |
WO (1) | WO2003091394A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080250883A1 (en) * | 2007-04-12 | 2008-10-16 | Fuji Xerox Co., Ltd. | Sensor chip and inspection device |
US8021614B2 (en) | 2005-04-05 | 2011-09-20 | The General Hospital Corporation | Devices and methods for enrichment and alteration of cells and other particles |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8304230B2 (en) | 2002-09-27 | 2012-11-06 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US10591391B2 (en) | 2006-06-14 | 2020-03-17 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US10704090B2 (en) | 2006-06-14 | 2020-07-07 | Verinata Health, Inc. | Fetal aneuploidy detection by sequencing |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692952B1 (en) * | 1999-11-10 | 2004-02-17 | Massachusetts Institute Of Technology | Cell analysis and sorting apparatus for manipulation of cells |
US7141369B2 (en) * | 2002-04-25 | 2006-11-28 | Semibio Technology, Inc. | Measuring cellular metabolism of immobilized cells |
WO2004077021A2 (en) * | 2003-02-27 | 2004-09-10 | Lesko Stephen A | Standardized evaluation of therapeutic efficacy based on cellular biomarkers |
US20070160503A1 (en) * | 2003-06-13 | 2007-07-12 | Palaniappan Sethu | Microfluidic systems for size based removal of red blood cells and platelets from blood |
AU2005218622A1 (en) * | 2004-03-03 | 2005-09-15 | Living Microsystems | Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
US20050218464A1 (en) * | 2004-03-18 | 2005-10-06 | Holm-Kennedy James W | Biochemical ultrasensitive charge sensing |
WO2005111630A1 (en) * | 2004-05-14 | 2005-11-24 | Tohoku Techno Arch Co., Ltd. | Method of immobilizing protein, protein chip, method of immobilizing cell and cell chip |
GB0425324D0 (en) * | 2004-11-17 | 2004-12-22 | Univ Edinburgh | Assay method |
EP1710579B1 (en) * | 2005-03-30 | 2014-07-30 | Sysmex Corporation | Method and apparatus for counting megakaryocytes |
US20070026413A1 (en) * | 2005-07-29 | 2007-02-01 | Mehmet Toner | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20070026414A1 (en) * | 2005-07-29 | 2007-02-01 | Martin Fuchs | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20070026417A1 (en) * | 2005-07-29 | 2007-02-01 | Martin Fuchs | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20070026415A1 (en) * | 2005-07-29 | 2007-02-01 | Martin Fuchs | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20090181421A1 (en) * | 2005-07-29 | 2009-07-16 | Ravi Kapur | Diagnosis of fetal abnormalities using nucleated red blood cells |
US20070026416A1 (en) * | 2005-07-29 | 2007-02-01 | Martin Fuchs | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20070059680A1 (en) * | 2005-09-15 | 2007-03-15 | Ravi Kapur | System for cell enrichment |
US20070059781A1 (en) * | 2005-09-15 | 2007-03-15 | Ravi Kapur | System for size based separation and analysis |
US20070059683A1 (en) * | 2005-09-15 | 2007-03-15 | Tom Barber | Veterinary diagnostic system |
WO2008111990A1 (en) * | 2006-06-14 | 2008-09-18 | Cellpoint Diagnostics, Inc. | Rare cell analysis using sample splitting and dna tags |
US20080023395A1 (en) * | 2006-07-31 | 2008-01-31 | Sigma Aldrich Co. | Compositions and Methods for Isolation of Biological Molecules |
US20080026375A1 (en) * | 2006-07-31 | 2008-01-31 | Sigma Aldrich Co. | Compositions and Methods for Isolation of Biological Molecules |
KR100956447B1 (en) * | 2008-05-16 | 2010-05-06 | 한국전자통신연구원 | A method for fabricating patterned biosensor substrate and a biosensor using the same |
WO2010129283A2 (en) * | 2009-04-27 | 2010-11-11 | The General Hospital Corporation | Microfluidic analyte capture using a thermoflowable material |
KR20210019599A (en) * | 2009-06-11 | 2021-02-22 | 미네르바 바이오테크놀로지 코포레이션 | Methods for culturing stem and progenitor cells |
CN101957378A (en) * | 2009-07-13 | 2011-01-26 | 上海汇中细胞生物科技有限公司 | CD4 (Cluster of Differentiation 4) cell chip as well as preparation method and application thereof |
US8187979B2 (en) * | 2009-12-23 | 2012-05-29 | Varian Semiconductor Equipment Associates, Inc. | Workpiece patterning with plasma sheath modulation |
WO2012009377A2 (en) | 2010-07-12 | 2012-01-19 | University Of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
US8845879B2 (en) * | 2010-11-24 | 2014-09-30 | Saint Louis Univesrity | Organelle bioelectrodes and methods of making and using the same |
US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
US9541480B2 (en) | 2011-06-29 | 2017-01-10 | Academia Sinica | Capture, purification, and release of biological substances using a surface coating |
US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
AU2013284452B2 (en) * | 2012-06-27 | 2017-08-31 | Siscapa Assay Technologies, Inc. | Multipurpose mass spectrometric assay panels for peptides |
FR2993988B1 (en) * | 2012-07-27 | 2015-06-26 | Horiba Jobin Yvon Sas | DEVICE AND METHOD FOR CHARACTERIZING A SAMPLE BY LOCALIZED MEASUREMENTS |
EP2885074B1 (en) * | 2012-08-17 | 2022-01-05 | Idev Technologies, Inc. | Surface oxide removal methods |
CN102879319B (en) * | 2012-10-17 | 2014-06-18 | 许旭欣 | Flow cell velocity measuring method for adjusting concentration of responding cells |
US10551376B2 (en) | 2013-02-01 | 2020-02-04 | The General Hospital Corporation | Capture and release of particles from liquid samples |
CN103743800B (en) * | 2013-12-26 | 2015-11-18 | 浙江大学 | For nanostructured lithium niobate electrode and the preparation method of glucose electrochemical sensing |
CN106662514A (en) | 2014-04-01 | 2017-05-10 | 中央研究院 | Methods and systems for cancer diagnosis and prognosis |
EP2998026B1 (en) | 2014-08-26 | 2024-01-17 | Academia Sinica | Collector architecture layout design |
US10107726B2 (en) | 2016-03-16 | 2018-10-23 | Cellmax, Ltd. | Collection of suspended cells using a transferable membrane |
US10718756B2 (en) * | 2016-10-27 | 2020-07-21 | The Regents Of The University Of California | Mitochondrial apoptotic sensor |
WO2019023961A1 (en) * | 2017-08-02 | 2019-02-07 | Suzhou Bofu Biomedical Limited | Method for capturing target cells or molecules in solution |
CN109254014A (en) * | 2018-10-19 | 2019-01-22 | 深圳市鹰眼在线电子科技有限公司 | Camera sensing device chip tester structure and method |
CN114062334B (en) * | 2021-10-25 | 2023-10-27 | 中国科学技术大学 | Fluorescent probe for measuring oxygen and hydrogen ions, preparation method and application |
CN114903030B (en) * | 2022-06-14 | 2024-03-01 | 安徽德维洛生物科技有限公司 | Preservation method of active nucleated cells |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4357142A (en) * | 1980-07-18 | 1982-11-02 | Akzona Incorporated | Glass support coated with synthetic polymer for bioprocess |
US4591570A (en) * | 1983-02-02 | 1986-05-27 | Centocor, Inc. | Matrix of antibody-coated spots for determination of antigens |
US4677061A (en) * | 1984-10-19 | 1987-06-30 | Genetic Systems Corporation | T-cell lymphocyte subset monitoring of immunologic disease |
US4952519A (en) * | 1988-05-02 | 1990-08-28 | E. I. Du Pont De Nemours And Company | Protein immobilization with poly(ethyleneimine) derivatized with a hydroprobic group |
US5100777A (en) * | 1987-04-27 | 1992-03-31 | Tanox Biosystems, Inc. | Antibody matrix device and method for evaluating immune status |
US5340719A (en) * | 1990-11-23 | 1994-08-23 | Corporation Coulter | Method and apparatus for optically screening microscopic cells |
US5348859A (en) * | 1990-11-23 | 1994-09-20 | Coulter Corporation | Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential |
US5554505A (en) * | 1990-11-23 | 1996-09-10 | Coulter Corporation | Method and apparatus for optically screening microscopic cells |
US5643721A (en) * | 1994-02-09 | 1997-07-01 | Abbott Laboratories | Bioreagent immobilization medium |
US5658745A (en) * | 1995-02-17 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Cell enumeration immunoassay |
US5716854A (en) * | 1990-10-01 | 1998-02-10 | Pharmacia Biosensor Ab | Solid phase binding assay |
US5866350A (en) * | 1985-03-19 | 1999-02-02 | Helen Hwai-An Lee | Method for the immunological determination of a biological material in a sample |
US6063637A (en) * | 1995-12-13 | 2000-05-16 | California Institute Of Technology | Sensors for sugars and other metal binding analytes |
US20010041347A1 (en) * | 1999-12-09 | 2001-11-15 | Paul Sammak | System for cell-based screening |
US20020076833A1 (en) * | 2000-08-01 | 2002-06-20 | Henry Michael R. | Analysis of biological samples utilizing a coated solid phase |
US6461825B1 (en) * | 1987-09-30 | 2002-10-08 | Sanofi (Societe Anonyme) | Immunometric assay kit and method applicable to whole cells |
US20020192676A1 (en) * | 2001-06-18 | 2002-12-19 | Madonna Angelo J. | Method for determining if a type of bacteria is present in a mixture |
US20040009471A1 (en) * | 2002-04-25 | 2004-01-15 | Bo Cao | Methods and kits for detecting a target cell |
US6767733B1 (en) * | 2001-10-10 | 2004-07-27 | Pritest, Inc. | Portable biosensor apparatus with controlled flow |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581223A (en) * | 1980-03-12 | 1986-04-08 | Lawrence Kass | Individual leukocyte determination by means of differential metachromatic dye sorption |
US4933278A (en) * | 1985-05-22 | 1990-06-12 | Monsanto Company | Method of determining the number of cells in cell culture |
DE3686474T2 (en) | 1985-10-11 | 1993-02-11 | Abbott Lab | DIAGNOSTIC SAMPLE. |
US5756696A (en) | 1986-01-16 | 1998-05-26 | Regents Of The University Of California | Compositions for chromosome-specific staining |
US4717545A (en) * | 1986-09-11 | 1988-01-05 | Miles Inc. | Device and method for chemical analysis of fluids with a reagent coated light source |
US4829010A (en) | 1987-03-13 | 1989-05-09 | Tanox Biosystems, Inc. | Immunoassay device enclosing matrixes of antibody spots for cell determinations |
JP2591641B2 (en) | 1988-02-19 | 1997-03-19 | 株式会社クラレ | Method and apparatus for measuring trace analyte substances |
CA2066643A1 (en) * | 1989-10-04 | 1991-04-05 | Richard Calvin Ebersole | Assay method for biological target complexes on the surface of a biosensor |
US5246832A (en) | 1990-06-20 | 1993-09-21 | University Of Massachusetts Medical Center | Platelet analysis in whole blood |
DE4026978A1 (en) * | 1990-08-25 | 1992-02-27 | Bayer Ag | Coated substrates for electro=optical applications, etc. |
US5296381A (en) * | 1991-08-08 | 1994-03-22 | Minnesota Mining & Manufacturing Co. | Sensing elements and methods for making and using same |
US6025126A (en) | 1991-10-28 | 2000-02-15 | Arch Development Corporation | Methods and compositions for the detection of chromosomal aberrations |
JP3111706B2 (en) | 1992-02-18 | 2000-11-27 | 株式会社日立製作所 | Particle analyzer and particle analysis method |
DE4208645A1 (en) | 1992-03-18 | 1993-09-23 | Bayer Ag | OPTICAL SOLID PHASE BIOSENSOR BASED ON FLUORESCENT COLOR-MARGINED POLYIONIC LAYERS |
US5379910A (en) * | 1992-12-16 | 1995-01-10 | Sunbeam Plastics Corporation | Apparatus for sealing a container and closure |
JP2634374B2 (en) | 1993-11-01 | 1997-07-23 | 株式会社バイオセンサー研究所 | Measuring device for trace analytes or organisms |
US5602042A (en) | 1994-04-14 | 1997-02-11 | Cytyc Corporation | Method and apparatus for magnetically separating biological particles from a mixture |
JP2691510B2 (en) | 1994-06-02 | 1997-12-17 | 株式会社バイオセンサー研究所 | Enzyme measuring device |
US6207369B1 (en) * | 1995-03-10 | 2001-03-27 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
US6017496A (en) * | 1995-06-07 | 2000-01-25 | Irori | Matrices with memories and uses thereof |
DE19530078A1 (en) * | 1995-08-16 | 1997-02-20 | Bayer Ag | Optical solid phase biosensor based on streptavidin and biotin |
US5879951A (en) | 1997-01-29 | 1999-03-09 | Smithkline Diagnostics, Inc. | Opposable-element assay device employing unidirectional flow |
JP3612675B2 (en) | 1997-06-05 | 2005-01-19 | 日本光電工業株式会社 | Apparatus and method for measuring pH change-inducing substance or organism |
WO1999054509A1 (en) * | 1998-04-20 | 1999-10-28 | Affymetrix, Inc. | Methods for reducing non-specific binding to a nucleic acid probe array |
US6303325B1 (en) | 1998-05-29 | 2001-10-16 | Dade Behring Inc. | Method for detecting analytes |
GB9912631D0 (en) | 1999-05-28 | 1999-07-28 | Nat Blood Authority The | Cell counter |
KR100751185B1 (en) * | 2000-08-08 | 2007-08-22 | 엘지.필립스 엘시디 주식회사 | Liquid Crystal Display Device And Method for Fabricating the same |
US6689478B2 (en) * | 2001-06-21 | 2004-02-10 | Corning Incorporated | Polyanion/polycation multilayer film for DNA immobilization |
US6766817B2 (en) | 2001-07-25 | 2004-07-27 | Tubarc Technologies, Llc | Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action |
-
2002
- 2002-04-25 US US10/132,543 patent/US7141369B2/en not_active Expired - Lifetime
-
2003
- 2003-04-22 AU AU2003223695A patent/AU2003223695A1/en not_active Abandoned
- 2003-04-22 WO PCT/US2003/012476 patent/WO2003091394A2/en not_active Application Discontinuation
- 2003-04-22 US US10/420,643 patent/US7855068B2/en active Active
-
2004
- 2004-03-03 US US10/793,104 patent/US20040214240A1/en not_active Abandoned
-
2007
- 2007-01-18 US US11/655,607 patent/US20070134713A1/en not_active Abandoned
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4357142A (en) * | 1980-07-18 | 1982-11-02 | Akzona Incorporated | Glass support coated with synthetic polymer for bioprocess |
US4591570A (en) * | 1983-02-02 | 1986-05-27 | Centocor, Inc. | Matrix of antibody-coated spots for determination of antigens |
US4677061A (en) * | 1984-10-19 | 1987-06-30 | Genetic Systems Corporation | T-cell lymphocyte subset monitoring of immunologic disease |
US5866350A (en) * | 1985-03-19 | 1999-02-02 | Helen Hwai-An Lee | Method for the immunological determination of a biological material in a sample |
US5100777A (en) * | 1987-04-27 | 1992-03-31 | Tanox Biosystems, Inc. | Antibody matrix device and method for evaluating immune status |
US6461825B1 (en) * | 1987-09-30 | 2002-10-08 | Sanofi (Societe Anonyme) | Immunometric assay kit and method applicable to whole cells |
US4952519A (en) * | 1988-05-02 | 1990-08-28 | E. I. Du Pont De Nemours And Company | Protein immobilization with poly(ethyleneimine) derivatized with a hydroprobic group |
US5716854A (en) * | 1990-10-01 | 1998-02-10 | Pharmacia Biosensor Ab | Solid phase binding assay |
US5554505A (en) * | 1990-11-23 | 1996-09-10 | Coulter Corporation | Method and apparatus for optically screening microscopic cells |
US5348859A (en) * | 1990-11-23 | 1994-09-20 | Coulter Corporation | Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential |
US5340719A (en) * | 1990-11-23 | 1994-08-23 | Corporation Coulter | Method and apparatus for optically screening microscopic cells |
US5643721A (en) * | 1994-02-09 | 1997-07-01 | Abbott Laboratories | Bioreagent immobilization medium |
US5658745A (en) * | 1995-02-17 | 1997-08-19 | E. I. Du Pont De Nemours And Company | Cell enumeration immunoassay |
US6063637A (en) * | 1995-12-13 | 2000-05-16 | California Institute Of Technology | Sensors for sugars and other metal binding analytes |
US20010041347A1 (en) * | 1999-12-09 | 2001-11-15 | Paul Sammak | System for cell-based screening |
US6716588B2 (en) * | 1999-12-09 | 2004-04-06 | Cellomics, Inc. | System for cell-based screening |
US20020076833A1 (en) * | 2000-08-01 | 2002-06-20 | Henry Michael R. | Analysis of biological samples utilizing a coated solid phase |
US20020192676A1 (en) * | 2001-06-18 | 2002-12-19 | Madonna Angelo J. | Method for determining if a type of bacteria is present in a mixture |
US6767733B1 (en) * | 2001-10-10 | 2004-07-27 | Pritest, Inc. | Portable biosensor apparatus with controlled flow |
US20040009471A1 (en) * | 2002-04-25 | 2004-01-15 | Bo Cao | Methods and kits for detecting a target cell |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US10081014B2 (en) | 2002-09-27 | 2018-09-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US11052392B2 (en) | 2002-09-27 | 2021-07-06 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8372579B2 (en) | 2002-09-27 | 2013-02-12 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8304230B2 (en) | 2002-09-27 | 2012-11-06 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US10786817B2 (en) | 2005-04-05 | 2020-09-29 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US9956562B2 (en) | 2005-04-05 | 2018-05-01 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8021614B2 (en) | 2005-04-05 | 2011-09-20 | The General Hospital Corporation | Devices and methods for enrichment and alteration of cells and other particles |
US8585971B2 (en) | 2005-04-05 | 2013-11-19 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US11674176B2 (en) | 2006-06-14 | 2023-06-13 | Verinata Health, Inc | Fetal aneuploidy detection by sequencing |
US10155984B2 (en) | 2006-06-14 | 2018-12-18 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US11781187B2 (en) | 2006-06-14 | 2023-10-10 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US10704090B2 (en) | 2006-06-14 | 2020-07-07 | Verinata Health, Inc. | Fetal aneuploidy detection by sequencing |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US10591391B2 (en) | 2006-06-14 | 2020-03-17 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US8166835B2 (en) * | 2007-04-12 | 2012-05-01 | Fuji Xerox Co., Ltd. | Sensor chip and inspection device |
US20080250883A1 (en) * | 2007-04-12 | 2008-10-16 | Fuji Xerox Co., Ltd. | Sensor chip and inspection device |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US10669585B2 (en) | 2008-09-20 | 2020-06-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
Also Published As
Publication number | Publication date |
---|---|
US7141369B2 (en) | 2006-11-28 |
US20070134713A1 (en) | 2007-06-14 |
AU2003223695A1 (en) | 2003-11-10 |
US20040009471A1 (en) | 2004-01-15 |
US20030203365A1 (en) | 2003-10-30 |
AU2003223695A8 (en) | 2003-11-10 |
US7855068B2 (en) | 2010-12-21 |
WO2003091394A2 (en) | 2003-11-06 |
WO2003091394A3 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7141369B2 (en) | Measuring cellular metabolism of immobilized cells | |
Wingard et al. | Biosensors with fiberoptics | |
Kuo et al. | Relationship between receptor/ligand binding affinity and adhesion strength | |
JP3537767B2 (en) | Method and apparatus for sensing the binding interaction between a binding layer and an analyte | |
Sternesjo et al. | Determination of sulfamethazine residues in milk by a surface plasmon resonance-based biosensor assay | |
Asanov et al. | Regenerable biosensor platform: a total internal reflection fluorescence cell with electrochemical control | |
Yakovleva et al. | Microfluidic enzyme immunoassay using silicon microchip with immobilized antibodies and chemiluminescence detection | |
CN102112877B (en) | Sensor | |
TW412637B (en) | Optical quantification of analytes in membranes | |
JPS6182166A (en) | Immunoassay system detecting and measuring object to be analyzed and assay method | |
CN102105798A (en) | Real-time continuous detection device | |
JP2020523555A (en) | Method for detecting extracellular vesicles in a sample | |
US10921322B2 (en) | Methods for detecting a marker for active tuberculosis | |
JPS59155762A (en) | Field immunoassay reaction system and method thereof | |
Mastichiadis et al. | Capillary-based immunoassays, immunosensors and DNA sensors–steps towards integration and multi-analysis | |
US20060246512A1 (en) | Biosensor | |
EP0988549B1 (en) | Modular assembly for reagentless affinity separation and detection of analyte | |
US20080248591A1 (en) | Gas bubble biosensor | |
JP2002174636A (en) | Device and method for measuring number and concentration of microorganism | |
Figueroa et al. | Antibody immobilization using pneumatic spray: Comparison with the avidin–biotin bridge immobilization method | |
Ramakrishna et al. | Polymer nanofibers for biosensor applications | |
US20240044770A1 (en) | Biosensor using particle motion | |
US20230160900A1 (en) | Method, Apparatus and System for Label-free Testing Whole Blood Specimen Using Fluidic Diffraction Chip | |
Zheng et al. | Biosensor | |
JPH03505920A (en) | Detection method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |